Question 1

How many institutions own SNPHY stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SNPHY shares is N/A, representing N/A of the company's common stock.

Question 2

Who are the major shareholders selling Santen Pharmaceutical Co., Ltd. stock?

Accepted Answer

RHUMBLINE ADVISERS, in the last quarter, reduced its stake in SNPHY by -97.49% restricting it's holding to 30 shares of worth nearly $333.00. COPELAND CAPITAL MANAGEMENT, LLC also lessened -100% of the SNPHY shares from its portfolio, reducing its holding to 0 shares of worth -. PNC FINANCIAL SERVICES GROUP, INC. also shunned SNPHY shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Question 3

Investors who are buying SNPHY stock?

Accepted Answer

As per its latest 13F filing, RHUMBLINE ADVISERS increased its stake in SNPHY by 3,890% in the last quarter. The institutional holder raised its holding to 1.2 thousand shares having worth more than $13.49K. COPELAND CAPITAL MANAGEMENT, LLC also added 24.35% more shares of SNPHY to its portfolio, raising its holding to 286 shares of worth $3.32K. PNC FINANCIAL SERVICES GROUP, INC. also increased its SNPHY shares holding by 100% which brought its holding to 26 shares worth $255.00.

Question 4

SNPHY's major insiders: who are they?

Accepted Answer

The insider with the most stakes in SNPHY is N/A , N/A at the company. Additionally, SNPHY stock is highly held by N/A N/A and N/A N/A among others.

Question 5

Did an insider recently sell SNPHY stock?

Accepted Answer

Company executives, directors, and other insiders own N/A percent of Santen Pharmaceutical Co., Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which SNPHY insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Question 6

Which insider recently purchased SNPHY stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Santen Pharmaceutical Co., Ltd. insiders have bought stock, totalling 0 shares

Question 7

How much of SNPHY does insiders own?

Accepted Answer

Around 0 Santen Pharmaceutical Co., Ltd. shares are held by insiders, which represents about N/A of SNPHY stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

SNPHY N/A, N/A holds the largest portfolio of the company's shares. SNPHY shares owned by N/A total nearly -.

Question 9

Which institution holds the most shares in SNPHY?

Accepted Answer

RHUMBLINE ADVISERS is the largest institutional owner in SNPHY which holds 30 shares worth $403.00 or 0% of the total SNPHY shares outstanding followed by RHUMBLINE ADVISERS with ownership of 30 shares representing 0% of the SNPHY ownership. COPELAND CAPITAL MANAGEMENT, LLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Question 10

Is Santen Pharmaceutical Co., Ltd. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SNPHY is concerned, it is a stock which is  optionable.

Question 11

Is there a short position on SNPHY's shares?

Accepted Answer

Number of SNPHY shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding SNPHY shares are there?

Accepted Answer

As of today, N/A shares of SNPHY are outstanding.

Question 13

Is there many float in SNPHY stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SNPHY has N/A shares in float.

Question 14

SNPHY short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SNPHY is N/A.

SNPHY Stock Ownership Breakdown

Santen Pharmaceutical Co

Stock Outstanding Shares

Institutional Ownership

Frequently Asked Questions

Stock Outstanding Shares

Institutional Ownership

Frequently Asked Questions

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2026	RHUMBLINE ADVISERS	0%	30	403	0	0
Mar 31, 2026	RHUMBLINE ADVISERS	0%	30	333	-1.17K	-97.49%
Mar 31, 2026	COPELAND CAPITAL MANAGEMENT, LLC	0%	0	-	-286	-100.00%
Dec 31, 2025	COPELAND CAPITAL MANAGEMENT, LLC	0%	286	2.95K	0	0
Dec 31, 2025	RHUMBLINE ADVISERS	0%	1.2K	12.33K	0	0
Sep 30, 2025	COPELAND CAPITAL MANAGEMENT, LLC	0%	286	3.22K	0	0
Sep 30, 2025	RHUMBLINE ADVISERS	0%	1.2K	13.49K	1.17K	+3,890.00%
Jun 30, 2025	RHUMBLINE ADVISERS	0%	30	348	0	0
Jun 30, 2025	COPELAND CAPITAL MANAGEMENT, LLC	0%	286	3.32K	56	+24.35%
Mar 31, 2025	COPELAND CAPITAL MANAGEMENT, LLC	0%	230	2.18K	0	0
Mar 31, 2025	PNC FINANCIAL SERVICES GROUP, INC.	0%	0	-	-26	-100.00%
Mar 31, 2025	RHUMBLINE ADVISERS	0%	30	284	0	0
Mar 31, 2024	PNC FINANCIAL SERVICES GROUP, INC.	0%	26	255	26	+100.00%
Mar 31, 2024	RHUMBLINE ADVISERS	0%	30	292	0	0
Dec 31, 2023	RHUMBLINE ADVISERS	0%	30	295	0	0
Sep 30, 2023	RHUMBLINE ADVISERS	0%	30	273	0	0